Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 848,155 Less Arrow 605,329 Less Arrow 392,830
Financial expenses 37,033 More Arrow 46,886 More Arrow 52,681
Earnings before taxes 206,206 Less Arrow 95,753 Less Arrow 21,107
EBITDA 160,653 Less Arrow 64,932 Less Arrow 45,949
Total assets 2,477,943 Less Arrow 2,224,224 Less Arrow 1,639,346
Current assets 838,523 Less Arrow 837,174 Less Arrow 442,222
Current liabilities 183,066 Less Arrow 136,241 Less Arrow 127,600
Equity capital 2,224,280 Less Arrow 1,970,392 Less Arrow 1,352,784
- share capital 830 Less Arrow 815 Less Arrow 721
Employees (average) 158 Less Arrow 130 Less Arrow 114

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 89.8% Less Arrow 88.6% Less Arrow 82.5%
Turnover per employee 5,368 Less Arrow 4,656 Less Arrow 3,446
Profit as a percentage of turnover 24.3% Less Arrow 15.8% Less Arrow 5.4%
Return on assets (ROA) 9.8% Less Arrow 6.4% Less Arrow 4.5%
Current ratio 458.0% More Arrow 614.5% Less Arrow 346.6%
Return on equity (ROE) 9.3% Less Arrow 4.9% Less Arrow 1.6%
Change turnover 231,911 Less Arrow 184,625 Less Arrow 148,419
Change turnover % 38% More Arrow 44% More Arrow 61%
Chg. No. of employees 28 Less Arrow 16 More Arrow 22
Chg. No. of employees % 22% Less Arrow 14% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.